Press Releases
-
IQVIA Selects Veeva Clinical Operations Applications
Oct 12, 2026
-
CluePoints Shortlisted for 2026 Scrip Awards Following 2023 and 2025 Wins
The two-time category winner secures finalist position in the Best Contract Research Organization (Specialist Providers) category.
Oct 13, 2026
-
Clinion’s Agentic AI Assistant Named Finalist for Technology Innovation of the Year at the Citeline Biotech Awards 2026
The recognition highlights Clinion’s work applying governed, multi-agent AI to clinical data management and study intelligence.
Oct 14, 2026
-
Paradigm Clinical Research Expands into Nevada with New Las Vegas Clinical Trial Site
Paradigm Clinical Research, Inc., a clinical research site organization, opens a clinical trial site in Las Vegas, marking the company’s ninth site location and expanding its geographic reach into one of the West’s largest and most diverse communities.
Oct 14, 2026
-
Panther Life Sciences’ SmartPatch™ Shows Favorable Skin Tolerability in First Clinical Study
First clinical results show Panther's microarray patch was well tolerated across eight applications over four weeks, with an efficacy study planned for later this year.
Oct 13, 2026
-
WeGuide Secures A$1.9M to Commercialise Digital Biomarkers
WeGuide has been awarded A$1.9 million in CUREator+ funding to build a platform that makes commercial digital biomarker development faster and cheaper, starting with a mobility recovery biomarker with NeuRA.
Aug 13, 2026
-
ELRIG and The Protein Society Announce Keynote Speakers for Protein Sciences in Drug Discovery 2026
• Prof Dame Carol Robinson (University of Oxford), Dr Andrew Doré (Isomorphic Labs) and Prof Paula Booth (King’s College London) to lead event taking place from 10–11 November at GSK Stevenage • Programme to focus on AI, machine learning and data-driven approaches across protein design, characterisation and therapeutic development
Oct 7, 2026
-
Global Congress on Nephrology and Kidney Health
May 19, 2027
-
Veeva DQS Cleans Data for More Than 1 Million Subjects Across Over 1,000 Studies
Oct 5, 2026
-
CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development
CellCarta today announced a strategic partnership with Waters Corporation creating a framework to jointly pursue companion diagnostic and next-generation flow cytometry opportunities with pharmaceutical and biotechnology companies.
Oct 4, 2026
-
Upperton Unveils New Brand Identity Reflecting Evolution into Specialist CDMO
Upperton has unveiled a new brand identity at CPHI Milan, marking a significant milestone in the company's evolution into a specialist, end-to-end contract development and manufacturing organisation (CDMO) focused on solving the challenges of molecule development across oral, nasal, pulmonary and parenteral dosage forms.
Oct 5, 2026
-
Industry Leading RBQM Event Returns for 2026
CluePoints sponsored RBQMLive 2026 will explore shift from adoption to operational maturity.
Sep 30, 2026
-
CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and Companion Diagnostic Programs Across Drug Development
CellCarta and Imagene AI today announced an expanded collaboration to provide a coordinated path for biopharma companies to validate, deploy, and scale AI-powered biomarker and companion diagnostic programs.
Sep 30, 2026
-
Advarra Launches Site Identification Technology with Insights Directly from Sites
Advarra today announced the launch of its new Site ID technology.
Sep 30, 2026
-
PumasAI Brings AI, Scientific Machine Learning and Advanced Pharmacometric Research to ACoP 2026
Pre-conference workshop on the future of AI in pharmacometrics and four scientific poster presentations highlight PumasAI’s presence at the American Conference on Pharmacometrics (ACoP)
Oct 1, 2026
-
Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth
Sep 30, 2026
-
Three new commercial appointments for Symbiosis to drive international growth
Sep 30, 2026
-
Ceryx Medical appoints Professor Zaheer Yousef OBE as Chief Medical Officer
Ceryx Medical has appointed Professor Zaheer Yousef OBE as Chief Medical Officer. Professor Yousef is a consultant cardiologist at the University Hospital of Wales and was principal investigator on RSA-Pace, Ceryx's multi-centre study of its respiratory sinus arrhythmia pacing technology. He joins as the company moves towards a clinical study designed to demonstrate the full clinical benefit of its implantable device in people living with heart failure.
Sep 20, 2026
-
Biopharma PEG Expands Functionalized PEG Linker Portfolio for Bioconjugation Research
Biopharma PEG expands its portfolio of functionalized PEG linkers for bioconjugation and pharmaceutical research, including azide, alkyne, DBCO, and BCN PEG derivatives, alongside monodispersed, polydispersed, and custom PEG solutions.
Sep 27, 2026
-
Huateng Pharma to Showcase High-Purity PEG Products and CDMO Capabilities at CPHI Milan 2026
Hunan Huateng Pharmaceutical Co., Ltd. will exhibit at CPHI Milan 2026, Booth 3H94, showcasing high-purity PEG products, pharmaceutical intermediates, APIs, and CDMO capabilities. The company supports pharmaceutical and biopharmaceutical projects from research and process development through manufacturing.
Sep 27, 2026


